Compare PGEN & IPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PGEN | IPI |
|---|---|---|
| Founded | 1998 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Mining & Quarrying of Nonmetallic Minerals (No Fuels) |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 380.0M |
| IPO Year | N/A | 2008 |
| Metric | PGEN | IPI |
|---|---|---|
| Price | $4.20 | $27.81 |
| Analyst Decision | Buy | Strong Sell |
| Analyst Count | 5 | 1 |
| Target Price | $7.67 | ★ $23.00 |
| AVG Volume (30 Days) | ★ 5.0M | 142.6K |
| Earning Date | 11-13-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $6,309,000.00 | ★ $222,728,000.00 |
| Revenue This Year | $342.78 | $23.99 |
| Revenue Next Year | $478.46 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 59.20 | 7.93 |
| 52 Week Low | $0.76 | $20.86 |
| 52 Week High | $5.23 | $39.01 |
| Indicator | PGEN | IPI |
|---|---|---|
| Relative Strength Index (RSI) | 54.86 | 59.05 |
| Support Level | $4.05 | $27.73 |
| Resistance Level | $4.53 | $28.66 |
| Average True Range (ATR) | 0.29 | 1.05 |
| MACD | 0.05 | 0.19 |
| Stochastic Oscillator | 69.99 | 64.88 |
Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.
Intrepid Potash Inc produces and sells potash and potash byproducts in three main product segments: Potash, Trio, and Oilfield Solutions. The Potash segment produces and sells potash to the agricultural industry as a fertilizer input, the industrial market as a component of oil and gas drilling fluid, and the animal feed market as a nutrient supplement. The Trio segment produces and sells specialty fertilizer that consists of potassium, sulfate, and magnesium and is mined from langbeinite ore. The oilfield solutions segment offers water, high-speed potassium chloride mixing services, saltwater disposal services, and trucking services. The vast majority of revenue is generated in the United States, which is also the location of the firm's production facilities.